US Stock MarketDetailed Quotes

CANF Can-Fite BioPharma

Watchlist

2.1350
+0.0450+2.15%

Close May 13 16:00 ET

10.65MMarket Cap-711P/E (TTM)

Can-Fite BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

11.71%8.92M

-26.55%7.94M

-24.67%9.62M

-25.66%12.42M

-58.27%7.99M

-20.86%10.81M

63.50%12.77M

43.87%16.7M

-Cash and cash equivalents

43.65%4.28M

-9.23%3.38M

101.99%3.46M

-77.03%1.26M

-32.16%2.98M

-35.81%3.73M

67.02%1.71M

100.58%5.5M

-Short-term investments

-7.29%4.64M

-35.66%4.56M

-44.29%6.16M

-0.40%11.15M

-66.04%5.01M

-9.81%7.09M

62.97%11.05M

26.32%11.2M

Other current assets

-15.73%986K

-35.96%1.12M

-29.07%1.29M

-0.93%962K

25.94%1.17M

116.03%1.75M

4.47%1.82M

-4.43%971K

Total current assets

8.20%9.91M

-27.86%9.06M

-25.22%10.91M

-24.30%13.38M

-54.37%9.16M

-13.19%12.57M

52.72%14.59M

39.98%17.67M

Non current assets

Net PPE

-35.71%81K

-25.53%105K

-21.66%123K

-36.78%110K

-31.89%126K

-14.55%141K

23.62%157K

48.72%174K

-Gross PPE

-8.02%344K

-25.53%105K

-21.66%123K

-36.78%110K

-10.74%374K

-14.55%141K

23.62%157K

48.72%174K

-Accumulated depreciation

-6.05%-263K

----

-5.98%-248K

----

Total non current assets

-35.71%81K

-25.53%105K

-21.66%123K

-36.78%110K

-31.89%126K

-14.55%141K

23.62%157K

48.72%174K

Total assets

7.61%9.99M

-27.84%9.17M

-25.19%11.03M

-24.42%13.49M

-54.16%9.28M

-13.20%12.71M

52.33%14.75M

40.06%17.85M

Liabilities

Current liabilities

Payables

-52.34%427K

-27.82%1.39M

9.16%1.41M

1.72%2.07M

-6.08%896K

73.72%1.93M

-1.98%1.29M

99.90%2.03M

-accounts payable

-52.34%427K

-56.05%647K

-1.70%810K

-14.32%963K

-6.08%896K

82.63%1.47M

-18.01%824K

287.59%1.12M

-Other payable

----

62.88%746K

28.45%596K

21.61%1.1M

----

50.16%458K

50.16%464K

24.93%907K

Current accrued expenses

-11.66%250K

----

-6.29%283K

----

Current debt and capital lease obligation

-43.75%27K

-29.17%34K

-6.38%44K

-23.64%42K

-9.43%48K

20.00%48K

9.30%47K

34.15%55K

-Current capital lease obligation

-43.75%27K

-29.17%34K

-6.38%44K

-23.64%42K

-9.43%48K

20.00%48K

9.30%47K

34.15%55K

Current deferred liabilities

-20.56%622K

-4.28%783K

-18.36%818K

Current liabilities

-19.26%2.02M

-20.96%2.21M

3.72%2.23M

-0.45%2.89M

-8.35%2.5M

29.87%2.8M

-8.73%2.15M

41.04%2.9M

Non current liabilities

Long term debt and capital lease obligation

-7.14%13K

-34.62%17K

-45.00%22K

-88.89%6K

-80.28%14K

-58.06%26K

60.00%40K

285.71%54K

-Long term capital lease obligation

-7.14%13K

-34.62%17K

-45.00%22K

-88.89%6K

-80.28%14K

-58.06%26K

60.00%40K

285.71%54K

Non current deferred liabilities

-25.36%1.71M

-30.50%1.71M

-28.49%1.9M

-26.74%2.1M

-25.24%2.3M

-20.52%2.46M

-20.35%2.66M

-20.22%2.87M

Total non current liabilities

-25.25%1.73M

-30.54%1.72M

-28.73%1.93M

-27.89%2.11M

-26.49%2.31M

-21.26%2.48M

-19.76%2.7M

-19.03%2.92M

Total liabilities

-22.14%3.75M

-25.46%3.93M

-14.34%4.16M

-14.20%5M

-18.05%4.81M

-0.51%5.28M

-15.21%4.85M

2.81%5.82M

Shareholders'equity

Share capital

--0

38.75%60.65M

63.89%60.65M

-common stock

--0

38.75%60.65M

63.89%60.65M

Retained earnings

-5.06%-158.48M

-6.09%-156.83M

-6.72%-155.07M

-7.19%-153.4M

-7.23%-150.85M

-10.35%-147.83M

-11.28%-145.3M

-12.38%-143.11M

Paid-in capital

6.10%163.6M

72.17%160.94M

72.16%160.81M

72.21%160.76M

0.17%154.19M

-5.06%93.48M

-3.09%93.41M

-3.05%93.35M

Gains losses not affecting retained earnings

0.00%1.13M

Total stockholders'equity

39.60%6.24M

-29.52%5.24M

-30.51%6.87M

-29.37%8.49M

-68.91%4.47M

-20.42%7.43M

150.11%9.89M

69.88%12.02M

Total equity

39.60%6.24M

-29.52%5.24M

-30.51%6.87M

-29.37%8.49M

-68.91%4.47M

-20.42%7.43M

150.11%9.89M

69.88%12.02M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	11.71%8.92M	11.71%8.92M	-26.55%7.94M	-24.67%9.62M	-25.66%12.42M	-58.27%7.99M	-58.27%7.99M	-20.86%10.81M	63.50%12.77M	43.87%16.7M
-Cash and cash equivalents	43.65%4.28M	43.65%4.28M	-9.23%3.38M	101.99%3.46M	-77.03%1.26M	-32.16%2.98M	-32.16%2.98M	-35.81%3.73M	67.02%1.71M	100.58%5.5M
-Short-term investments	-7.29%4.64M	-7.29%4.64M	-35.66%4.56M	-44.29%6.16M	-0.40%11.15M	-66.04%5.01M	-66.04%5.01M	-9.81%7.09M	62.97%11.05M	26.32%11.2M
Other current assets	-15.73%986K	-15.73%986K	-35.96%1.12M	-29.07%1.29M	-0.93%962K	25.94%1.17M	25.94%1.17M	116.03%1.75M	4.47%1.82M	-4.43%971K
Total current assets	8.20%9.91M	8.20%9.91M	-27.86%9.06M	-25.22%10.91M	-24.30%13.38M	-54.37%9.16M	-54.37%9.16M	-13.19%12.57M	52.72%14.59M	39.98%17.67M
Non current assets
Net PPE	-35.71%81K	-35.71%81K	-25.53%105K	-21.66%123K	-36.78%110K	-31.89%126K	-31.89%126K	-14.55%141K	23.62%157K	48.72%174K
-Gross PPE	-8.02%344K	-8.02%344K	-25.53%105K	-21.66%123K	-36.78%110K	-10.74%374K	-10.74%374K	-14.55%141K	23.62%157K	48.72%174K
-Accumulated depreciation	-6.05%-263K	-6.05%-263K	----	----	----	-5.98%-248K	-5.98%-248K	----	----	----
Total non current assets	-35.71%81K	-35.71%81K	-25.53%105K	-21.66%123K	-36.78%110K	-31.89%126K	-31.89%126K	-14.55%141K	23.62%157K	48.72%174K
Total assets	7.61%9.99M	7.61%9.99M	-27.84%9.17M	-25.19%11.03M	-24.42%13.49M	-54.16%9.28M	-54.16%9.28M	-13.20%12.71M	52.33%14.75M	40.06%17.85M
Liabilities
Current liabilities
Payables	-52.34%427K	-52.34%427K	-27.82%1.39M	9.16%1.41M	1.72%2.07M	-6.08%896K	-6.08%896K	73.72%1.93M	-1.98%1.29M	99.90%2.03M
-accounts payable	-52.34%427K	-52.34%427K	-56.05%647K	-1.70%810K	-14.32%963K	-6.08%896K	-6.08%896K	82.63%1.47M	-18.01%824K	287.59%1.12M
-Other payable	----	----	62.88%746K	28.45%596K	21.61%1.1M	----	----	50.16%458K	50.16%464K	24.93%907K
Current accrued expenses	-11.66%250K	-11.66%250K	----	----	----	-6.29%283K	-6.29%283K	----	----	----
Current debt and capital lease obligation	-43.75%27K	-43.75%27K	-29.17%34K	-6.38%44K	-23.64%42K	-9.43%48K	-9.43%48K	20.00%48K	9.30%47K	34.15%55K
-Current capital lease obligation	-43.75%27K	-43.75%27K	-29.17%34K	-6.38%44K	-23.64%42K	-9.43%48K	-9.43%48K	20.00%48K	9.30%47K	34.15%55K
Current deferred liabilities	-20.56%622K	-20.56%622K	-4.28%783K	-4.28%783K	-4.28%783K	-4.28%783K	-4.28%783K	-18.36%818K	-18.36%818K	-18.36%818K
Current liabilities	-19.26%2.02M	-19.26%2.02M	-20.96%2.21M	3.72%2.23M	-0.45%2.89M	-8.35%2.5M	-8.35%2.5M	29.87%2.8M	-8.73%2.15M	41.04%2.9M
Non current liabilities
Long term debt and capital lease obligation	-7.14%13K	-7.14%13K	-34.62%17K	-45.00%22K	-88.89%6K	-80.28%14K	-80.28%14K	-58.06%26K	60.00%40K	285.71%54K
-Long term capital lease obligation	-7.14%13K	-7.14%13K	-34.62%17K	-45.00%22K	-88.89%6K	-80.28%14K	-80.28%14K	-58.06%26K	60.00%40K	285.71%54K
Non current deferred liabilities	-25.36%1.71M	-25.36%1.71M	-30.50%1.71M	-28.49%1.9M	-26.74%2.1M	-25.24%2.3M	-25.24%2.3M	-20.52%2.46M	-20.35%2.66M	-20.22%2.87M
Total non current liabilities	-25.25%1.73M	-25.25%1.73M	-30.54%1.72M	-28.73%1.93M	-27.89%2.11M	-26.49%2.31M	-26.49%2.31M	-21.26%2.48M	-19.76%2.7M	-19.03%2.92M
Total liabilities	-22.14%3.75M	-22.14%3.75M	-25.46%3.93M	-14.34%4.16M	-14.20%5M	-18.05%4.81M	-18.05%4.81M	-0.51%5.28M	-15.21%4.85M	2.81%5.82M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	38.75%60.65M	63.89%60.65M	63.89%60.65M
-common stock	--0	--0	--0	--0	--0	--0	--0	38.75%60.65M	63.89%60.65M	63.89%60.65M
Retained earnings	-5.06%-158.48M	-5.06%-158.48M	-6.09%-156.83M	-6.72%-155.07M	-7.19%-153.4M	-7.23%-150.85M	-7.23%-150.85M	-10.35%-147.83M	-11.28%-145.3M	-12.38%-143.11M
Paid-in capital	6.10%163.6M	6.10%163.6M	72.17%160.94M	72.16%160.81M	72.21%160.76M	0.17%154.19M	0.17%154.19M	-5.06%93.48M	-3.09%93.41M	-3.05%93.35M
Gains losses not affecting retained earnings	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M	0.00%1.13M
Total stockholders'equity	39.60%6.24M	39.60%6.24M	-29.52%5.24M	-30.51%6.87M	-29.37%8.49M	-68.91%4.47M	-68.91%4.47M	-20.42%7.43M	150.11%9.89M	69.88%12.02M
Total equity	39.60%6.24M	39.60%6.24M	-29.52%5.24M	-30.51%6.87M	-29.37%8.49M	-68.91%4.47M	-68.91%4.47M	-20.42%7.43M	150.11%9.89M	69.88%12.02M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall